Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 34.64
-0.91 (-2.56%)
Jun 22, 2026, 4:00 PM EDT
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 3.43 billion as of June 22, 2026. Its market cap has decreased by -36.46% in one year.
Market Cap
3.43B
Enterprise Value
2.71B
Revenue
46.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.64
Market Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 3.43B, an increase of 15.08%. That is a compound annual growth rate of 3.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 3.43B | -29.55% |
| Dec 31, 2025 | 4.87B | 60.11% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
| Apr 12, 2022 | 2.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assure Tech (Hangzhou) | 3.83B |
| ChemPartner PharmaTech | 3.81B |
| Beijing Bohui Innovation Biotechnology Group | 3.64B |
| Kexing Biopharm | 3.62B |
| Hefei Lifeon Pharmaceutical | 3.50B |
| Shanghai Obio Technology (Group) Corp. | 3.50B |
| Shanghai Shen Lian Biomedical | 3.46B |
| Baolingbao Biology | 3.39B |